Evidence map›Paper›PMID 40281507›Full record

ArticleBMC ophthalmology2025

Epidemiology of oculo-orbital tumours in Malawian children: a 10-year review of cases from tertiary hospitals.

Grace Obumneke Ogbonna, Miriam Chikhoza, Michael Agyemang Kwarteng, Ngozika Esther Ezinne, Rosemary Ehigbor, Obinna Princewill Anyatonwu, Osamudiamen McHillary Ogiemudia

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Grace Obumneke OgbonnaDepartment of Optometry, Faculty of Health Sciences, Mzuzu University, Mzuzu, Malawi. ogbonnagrace19@gmail.com.ORCID https://orcid.org/0000-0002-1728-0067
Miriam ChikhozaDepartment of Optometry, Faculty of Health Sciences, Mzuzu University, Mzuzu, Malawi.
Michael Agyemang KwartengOptometry Unit, Department of Clinical Surgical Sciences, Faculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago, St Augustine Campus, Port of Spain, Trinidad and Tobago.ORCID https://orcid.org/0000-0003-1072-315X
Ngozika Esther EzinneOptometry Unit, Department of Clinical Surgical Sciences, Faculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago, St Augustine Campus, Port of Spain, Trinidad and Tobago.ORCID https://orcid.org/0000-0003-3138-0213
Rosemary EhigborAbia State Specialist Hospital, Umuahia, Abia State, Nigeria.
Obinna Princewill AnyatonwuLife Science Nigeria, Umuahia, Nigeria.ORCID https://orcid.org/0009-0006-4657-7720
Osamudiamen McHillary OgiemudiaDepartment of Optometry, College of Medical and Health Sciences, Novena University, Ogume, Delta State, Nigeria.ORCID https://orcid.org/0000-0003-1182-3822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOcular tumours, regardless of type, impose significant economic and psychosocial burdens on sufferers and their families [1]. Paediatric cases can lead to substantial challenges, including developmental delays, economic strain, and psychological distress. The aim of this study was to determine the prevalence and presentation of ocular tumours among children in Malawi.

methodThe study was designed as a hospital-based cross-sectional retrospective review of paediatric files obtained from the Ophthalmology Department of the four tertiary hospitals (Kamuzu, Queen Elizabeth, Mzuzu and Zomba Central Hospitals) in Malawi from 2009 to 2019. Data was analysed using the Statistical Package for the Social Sciences version 26.0 for data analysis. A p-value of < 0.05 was considered statistically significant.

resultsA total of 1,014 out of 40,423 children were diagnosed with ocular tumours representing an overall prevalence of 2.51% (CI: 2.36-2.67). Among them, 485 were females (47.8%) and 529 males (52.2%), which was not statistically significant (p = 0.426). Most (46.1%) of the cases were from the Queen Elizabeth Central hospital with most cases recorded in 2019. Patients aged 3-5 years had the most cases of ocular tumours. Retinoblastoma was the most prevalent malignant tumour (41.6%), while dermoid cysts was the most common (20.7%) benign tumour. Tumours were more frequently found in the left eye (51.1%) compared to the right eye (43.8%), with 5.1% involving both eyes. The proportion difference in laterality between the right and left eye was statistically significant (p = 0.012). Imaging was performed in 10.0% of cases, with MRI being the most common (6.5%), followed by B-scan (2.4%), CT-scan (0.9%), among others. Surgical procedures were performed in 80.4% of cases, with excision being the most common (47.3%), followed by enucleation (27.2%), and exenteration (4.2%).

conclusionThe study observed a high prevalence of ocular malignancies with children aged 3 to 5 years being the most affected age group. Surgical excision was the main stay of treatment for children affected by ocular tumours in Malawi. Poor diagnostic and therapeutic options remain a big limitations to the provision of care for this population as such there is an urgent need to improve paediatric oncology services in Malawi. Policymakers and healthcare providers must prioritize investments in diagnostic infrastructure, training, and integrated care pathways to enhance the management of paediatric ocular tumours and improve survival rates.

Indexed as

Eye NeoplasmsOrbital NeoplasmsTertiary Care CentersAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornMalawiMalePrevalenceRetinoblastomaRetrospective StudiesExenterationMalawiPediatricPolicy makersTumous

Identifiers

PMID40281507
PMCPMC12023627

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.